<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-12.anc" start="23072" end="23083" sStart="-1" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="For ligand blot assays, samples separated by SDS-PAGE (9%) were &lt;b&gt;transferred&lt;/b&gt; to PVDF overnight, blocked with 5% dried milk in TTBS (50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20, pH 7.5)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="10179" end="10185" sStart="null" offset="202" sid="r11.strong.j.0696" wn="5 6 1" wnkey="null" text="A weak to moderate cross-reactivity with anti-BT-R 1 was observed for B. mori BBMV as well as the putative cadherin-like receptor fraction, providing strong evidence that the material is a cadherin-like protein (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="10589" end="10595" sStart="null" offset="141" sid="r11.strong.j.0255" wn="2147483644" wnkey="null" text="Similar antibody assays were not performed to substantiate the identity of the purified APN because it clearly displayed strong, characteristic APN enzyme activity." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-2-12.anc" start="1971" end="1976" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" text="This receptor was &lt;b&gt;shown&lt;/b&gt; to bind Cry1Aa with a 7.6 nM affinity, as determined by Scatchard analysis with ELISA binding assays [ 6 ] . The APN was cloned and expressed in E. coli and demonstrated to bind Cry1Aa toxin on ligand blots [ 7 ] . These results indicate the Cry1Aa-APN interaction was specific and that APN glycosylation was not required for Cry1Aa binding." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="13459" end="13469" sStart="null" offset="21" sid="r10.particular.j.0681" wn="3" wnkey="particular%5:00:00:uncommon:00" text="Hybrid toxin 4109 is particular useful in this context, because it is comprised of domains I and II from Cry1Aa and domain III from Cry1Ac (Aa/Aa/Ac) [ 3 ] . Hybrid-toxin 4109 binding to both receptors was not noticeably different from Cry1Aa: for APN binding, k a = 1.9 ? 10 4M -1s -1(+/- 1.4 ? 10 2), k d = 1.5 ? 10 -3s -1(+/- 1.6 ? 10 -5), and K D = 78 nM; for cadherin binding, k a = 1.3 ? 10 4M -1s -1(+/- 2 ? 10 2), k d = 3.34 ? 10 -5s -1(+/- 2 ? 10 -5), and K D = 2.6 nM." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-2-12.anc" start="18106" end="18112" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" text="Additionally, structural information will aid in the rational construction of toxins with reduced binding for beneficial insects without &lt;b&gt;losing&lt;/b&gt; activity to target pests." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="17416" end="17420" sStart="null" offset="179" sid="r10.high.j.0487" wn="1" wnkey="high%3:00:02::" text="[ 21 ] . However, Heliothis virescens (tobacco budworm) APN is only 45% identical and 53% similar to B. mori APN, yet it binds Cry1Aa toxin with high affinity [ 23 ] . Moreover, sequence alignments with APN from Lactobacillus , Streptococcus , Saccharomyces , Arabidopsis , rat, pig, yeast, and human yielded more similarity than H. virescens APN to the putative Cry1Aa-binding region of B. mori APN." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="17871" end="17875" sStart="null" offset="121" sid="r10.help.v.0543" wn="3" wnkey="help%2:42:00::" text="It is likely that as the X-ray crystal structures of APNs are solved, structural alignments of APNs will help resolve the specificity-determining regions more accurately." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="2767" end="2776" sStart="null" offset="145" sid="r11.function.n.0262" wn="2" wnkey="function%1:07:00::" text="Sequence alignments with Plutella xylostella APN receptor indicate that a highly conserved region of APN likely functions as the toxin binding site [ 9 ] . By testing for toxin binding to lysylendopeptidase-digested B. mori APN fragments, the toxin binding site was suggested to be between Ile135 and Pro198." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="9022" end="9028" sStart="null" offset="22" sid="r9.appear.v.0161" wn="1" wnkey="appear%2:39:00::" text="Several BBMV proteins appear present in the APN-containing fraction prior to size-exclusion purification (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="8850" end="8857" sStart="null" offset="45" sid="r9.appear.v.0231" wn="5" wnkey="appear%2:30:02::" text="The putative cadherin-like receptor material appears at a molecular size around 180 kDa, both before and after secondary purification (Lanes 2 and 1, respectively)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="17174" end="17180" sStart="null" offset="14" sid="r9.appear.v.0366" wn="1" wnkey="appear%2:39:00::" text="These results appear to support the findings of Yaoi et al." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-2-12.anc" start="1792" end="1799" sStart="null" offset="116" sid="r9.appear.v.0222" wn="5" wnkey="appear%2:30:02::" text="The first toxin-binding receptor purified from B. mori was a 120-kDa aminopeptidase N (APN), which appears around 110-kDa on SDS-PAGE gels when preparative conditions are used that cleave its glycosyl-phosphatidylinositol (GPI) anchor." />
  </sentences>
</list>